Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Anish Patel

COO at Enliven Therapeutics, Inc. (ELVN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.7M

Reported trades

Filed Stock Type Shares Price Value Since
Jan 13SEC ELVNEnliven Therapeutics, Inc. Sell Plan 48,057215,254 held (−18%) $27.98 $1.3M +46.5%
Jan 13SEC ELVNEnliven Therapeutics, Inc. Sell Plan 243215,011 held (−0%) $28.50 $7K +43.8%
Dec 10SEC ELVNEnliven Therapeutics, Inc. Sell Plan 4,958265,016 held (−2%) $20.76 $103K +97.4%
Dec 10SEC ELVNEnliven Therapeutics, Inc. Sell Plan 1,705263,311 held (−1%) $21.78 $37K +88.2%
Nov 12SEC ELVNEnliven Therapeutics, Inc. Sell Plan 6,054270,587 held (−2%) $17.35 $105K +136.2%
Nov 12SEC ELVNEnliven Therapeutics, Inc. Sell Plan 613269,974 held (−0%) $17.94 $11K +128.4%
Oct 9SEC ELVNEnliven Therapeutics, Inc. Sell Plan 6,667276,641 held (−2%) $20.10 $134K +103.9%
  • Sell

    COO Anish Patel sold $1.3M of ELVN at $27.98 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Anish Patel sold $7K of ELVN at $28.50 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Anish Patel sold $103K of ELVN at $20.76 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Anish Patel sold $37K of ELVN at $21.78 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Anish Patel sold $105K of ELVN at $17.35 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Anish Patel sold $11K of ELVN at $17.94 — pre-scheduled 10b5-1 plan sale.